Please Wait
Applying Filters...
menu
    • menu
    Strides Pharma Science-PSE
    News
    Astra eyes 5th Ultomiris indication after kidney disease trial

    22 Apr 2026

    // PRESS RELEASE

    Roche’s Enspryng cuts relapse risk by 68% in Neuroinflammatory

    22 Apr 2026

    // PRESS RELEASE

    US FDA approves Merck's pill combo to treat HIV

    22 Apr 2026

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Beltapharm SPA

    Contact Supplier

    Website

    AACR Annual meeting

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued
    Menu

    Beltapharm SPA

    EVENTS

    • Webinars & Exhibitions

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Beltapharm SPA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    AACR Annual meeting
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-07-14

    Beltapharm SPA

    City : Cusano Milanino

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-07-14

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    AACR Annual meeting
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2019-03-29

    Beltapharm SPA

    City : Cusano Milanino

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2019-03-29

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    arrow
    AACR Annual meeting
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-15

    Beltapharm SPA

    City : Cusano Milanino

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-15

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    arrow
    AACR Annual meeting
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Beltapharm SPA

    City : Cusano Milanino

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.